hCD19/hCD8A
Nomenclature
C57BL/6JSmo-Cd8atm1(hCD8A)Cd19tm1(hCD19)Smoc
Cat. NO.
NM-XA-252035
Strain State
Repository Live
Model Description
Validation Data
Fig.1 Detection of CD8 expression on T cells in blood and spleen of WT C57BL/6 mice and hCD19/hCD8A mice by FACS. Blood and spleen were collected from WT C57BL/6 mice (male, 11 weeks old) and homozygous hCD19/hCD8A humanized mice (male, 11 weeks old). CD8 expression was analyzed from CD3+ population. hCD8 was exclusively detectable in the blood and spleen of HO hCD19/hCD8A humanized mice but not in WT mice, whereas mCD8 was exclusively detectable on T cells in WT C57BL/6 mice.
Abbr. HO, homozygous; WT, wild type.
Fig.2 Detection of CD19 expression on B cells in blood and spleen of WT C57BL/6 mice and hCD19/hCD8A mice by FACS. Blood and spleen were collected from WT C57BL/6 mice (male, 11 weeks old) and homozygous hCD19/hCD8A humanized mice (male, 11 weeks old). CD19 expression was analyzed from CD3- population. hCD19 was exclusively detectable in the blood and spleen of HO hCD19/hCD8A humanized mice but not in WT mice, whereas mCD19 was exclusively detectable on B cells in WT C57BL/6 mice.
Abbr. HO, homozygous; WT, wild type.
Table 1 Blood routine examination in hCD19/hCD8A mice (n=4 /group).
Table 2 Blood biochemistry examination in hCD19/hCD8A (n=4 /group).
Fig.3 Representative figure of leukocyte and myeloid subpopulations in blood in HO hCD19/hCD8A mice. T cells, B cells, NK cells, CD11b+myeloid cells, DCs, neutrophils, monocytes, and macrophages in the blood of HO hCD19/hCD8A mice showed comparable to those in WT C57BL/6 mice. Percentages of T cells, B cells, NK cells, CD11b+myeloid cells, DCs, neutrophils, monocytes, and macrophages in the blood of HO hCD19/hCD8A mice showed comparable to those in WT C57BL/6 mice.
Fig.4 Representative figure of leukocyte and myeloid subpopulations in spleen in HO hCD19/hCD8A mice. T cells, B cells, NK cells, CD11b+myeloid cells, DCs, neutrophils, monocytes, and macrophages in the spleen of HO hCD19/hCD8A mice showed comparable to those in WT C57BL/6 mice. Percentages of T cells, B cells, NK cells, CD11b+myeloid cells, DCs, neutrophils, monocytes, and macrophages in the spleen of HO hCD19/hCD8A mice showed comparable to those in WT C57BL/6 mice.
Fig.5 Frequency of leukocyte and myeloid subpopulations in blood and spleen by flow cytometry. Blood and spleen was collected from WT C57BL/6 mice and HO hCD19/hCD8A mice (10-week-old, n=3). Flow cytometry analysis of frequencies of leukocyte and myeloid subpopulations in (A) blood and (B) spleen. Bar indicated expressed as mean ± SEM. Percentages of T cells, B cells, NK cells，CD11b+myeloid cells, DCs, neutrophils, monocytes, and macrophages in the blood and spleen of HO hCD19/hCD8A mice showed comparable to those in WT C57BL/6 mice.
Abbr. HO, homozygous; WT, wild type.
You may also like
Workshop：Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn moreShanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreCustomizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more
